9.36 USD
↘ 0.64 (6.40%)AT CLOSE (11:59 AM EDT)
Palatin Technologies, Inc. Common Stock
PTNNASDAQ • USD
9.53
↗ 0.17 (1.82%)
POST MARKET (AS OF 07:35 PM EDT)
Post Market
AS OF 07:35 PM EDT
9.53
↗ 0.17 (1.82%)
Market: CLOSED
Palatin Technologies, Inc. Common Stock (PTN) trades at $9.36 per share. Technicals currently rate "Neutral" while our fundamental analysis reads "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, PTN appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Aug 14, 2026.
Open?$10.27
High?$10.27
Low?$8.81
Prev. Close?$10.00
Volume?12.3K
Avg. Volume?18.4K
VWAP?$9.79
Rel. Volume?0.67x
Bid / Ask
Bid?$10.26 × 100
Ask?$10.77 × 100
Spread?$0.51
Midpoint?$10.52
Valuation & Ratios
Market Cap?16.7M
Shares Out?1.8M
Float?1.6M
Float %?92.0%
P/E Ratio?N/A
P/B Ratio?1.57
EPS?-$3.51
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science.
Address
4B CEDAR BROOK DRIVE
CRANBURY, NJ 08512
Phone: 609-495-2200
CRANBURY, NJ 08512
Phone: 609-495-2200
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?65
Short Sent.?19
Piotroski F-Score?0/9Weak
Altman Z-Score?-45.64Distress
Confidence?49%Low
Short InterestVery High
Short % of Float?18.13%High
Short Interest?296.7K
Days to Cover?29.8
Free Float1.6M
Avg Daily Volume10.0K
Settlement Date2026-07-31
Financial Health
Current Ratio?5.04Strong
Quick Ratio?5.04Strong
Cash Ratio?4.01Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.57CHEAP▾
Peers100
S&P85
P/S?1.29CHEAP▾
Peers100
S&P82
P/FCF?N/A▾
EV/EBITDA?-0.7CHEAP▾
S&P97
EV/Sales?0.50CHEAP▾
Peers100
S&P97
Returns & Efficiency
ROE?-59.0%WEAK▾
S&P3
ROA?-47.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-14983631
Enterprise Value?$6.5M
Fundamentals ratios updated end of day